Big Pharma’s patents on kratom alkaloids expose real reason DEA is banning this plant
“Currently, the pharmaceutical industry is using kratom alkaloids to manufacture synthetic opioids…kratom will be illegal, but the synthetic patented and monopolized version will not.”
Cannabis is a schedule one substance but the pharmaceutical industry can manufacture a synthetic version of the same active ingredient in cannabis, THC, and it magically becomes legal. As Cassius Kamarampi points out, three synthetic opioids, in particular, were synthesized from the alkaloids in kratom from 2008- 2016: MGM-9, MGM-15, and MGM-16. They were synthesized from kratom’s alkaloids Mitragynine and 7-Hydroxymitragynine: to make what is essentially patentable, pharmaceutical kratom. The patent was filed by Smith Kline, of Glaxo Smith Kline, & French Laboratories. See the pattern yet? As the legal pain medication epidemic sweeps the nation killing thousands every year and converting its users into heroin addicts, the pharmaceutical companies are scrambling to find an alternative. Kratom could be that alternative. However, since kratom can be grown in your backyard, pharmaceutical companies can’t monopolize it — unless the government outlaws it. On September 30, 2016 kratom will be illegal, but the synthetic patented and monopolized version will not.
Original Article (Alternet):
Big Pharma’s patents on kratom alkaloids expose real reason DEA is banning this plant
Artwork Fair Use: Uomo vitruviano
